Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
The spread of novel betacoronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly escalated to a pandemic unseen for generations. With ramifications not before witnessed during peacetime, the medical community stands to face a very tough year.
Cancer patients represent a population at elevated risk for serious viral disease due to the immunosuppressive nature of both malignancy and anticancer treatments such as chemotherapy.1-3 Therefore, cancer patients may be at an increased risk of COVID-19 infection and henceforth face a poorer prognosis.